Please look at the cube carefully for a couple of seconds. Which face appears to be in front—the upper-right or the lower-left? They seem to flip, don’t they? Both interpretations are equally consistent with the
same visual information. Such experiences are known as bistable percepts. We use this phenomenon to illustrate a broader principle: a diagnostic label such as diabetes may identify the same medical condition
across individuals, yet its experience, burden, consequences, and possibilities for care can differ profoundly depending on each person’s biological, psychological, and social context. The CIBEM Framework seeks to understand
these contextual differences and incorporate them into evidence-based healthcare, enabling care to become contextualized and individualized.
A diagnosis may name a disease, but it cannot fully describe a person’s health. The WHO’s International Classification of Functioning, Disability and Health (ICF) provides a biopsychosocial framework for understanding health and functioning
through the interaction of a health condition with body functions and structures, activities, participation, and the environmental and personal contexts in which people live. CIBEM takes this idea further by asking two simple questions:
How easy is it for a person to attain and sustain health within their biopsychosocial context? And do they have what is needed to do so? The Ease-of-Health and Knowledge-of-Health Indices are our attempts to make the answers measurable
and ultimately actionable.
Contextualization and Individualization of Evidence-Based Medicine
Disease burden is not static. It unfolds over time within a person’s biological, psychological, and social context. INDHEX seeks to characterize this changing biopsychosocial burden of disease longitudinally,
capturing how illness is experienced and how its burden evolves across the course of disease and care. The program investigates these trajectories across six disciplines: psychiatry, neurology, immunology, endocrinology, infectious diseases, and dentistry.
By following interacting dimensions of burden over time, INDHEX aims to move beyond snapshots of disease severity towards a dynamic understanding of disease trajectories that can inform increasingly contextualized and individualized
healthcare.
Health challenges cannot always be addressed through solutions developed in different biological, socioeconomic, and healthcare contexts. EMCORT seeks to develop context-relevant innovations by translating
real-world evidence into technologies, interventions, and healthcare solutions tailored to the needs of emerging economies. By integrating insights from biological, psychological, social, environmental, and healthcare-system
determinants, the program designs practical innovations that attenuate the biopsychosocial burden of health and disease. The technologies and interventions developed through EMCORT support health promotion, disease prevention,
healthcare delivery, and equitable, context-sensitive care across CIBEM's six clinical disciplines: psychiatry, neurology, immunology, infectious diseases, endocrinology, and dentistry.
Health and disease create economic consequences that extend beyond the costs of medical care. MEHEC investigates how the biopsychosocial burden of disease translates into economic impact for individuals, patients, families,
communities, and health systems. By characterizing biological, psychological, and social burdens alongside the opportunities that exist within these same contexts, the program seeks to identify where economic interventions
can reduce burden, strengthen capabilities, and improve health. MEHEC develops and evaluates such context-sensitive economic interventions across CIBEM’s six clinical disciplines: psychiatry, neurology, immunology, infectious
diseases, endocrinology, and dentistry.
Improving health and reducing the biopsychosocial burden of disease requires a human-resource ecosystem that extends far beyond clinicians. HEAR-EM seeks to characterize the knowledge, skills, roles, relationships, and collaborative capacities distributed across clinicians, researchers, educators, technologists, community health workers, policymakers, caregivers, entrepreneurs, and other societal stakeholders. By mapping how these human resources interact around
individuals and communities, the program seeks to identify gaps, complementarities, and opportunities for more effective collaboration. HEAR-EM uses this evidence to inform context-sensitive workforce strategies and collaborative
health networks across CIBEM’s six clinical disciplines: psychiatry, neurology, immunology, infectious diseases, endocrinology, and dentistry.
The Evidence-based Communication for Health Outcomes (ECHO) Program investigates how health communication can be contextualized to the biological, psychological, social, cultural, linguistic, ethical, regulatory,
and environmental realities in which people live. ECHO structures communication across four sequential dimensions: audience, purpose, format, and channel, examining how each influences the way evidence-based
health information is perceived, understood, and acted upon. The program seeks to develop and evaluate context-sensitive communication approaches that strengthen health promotion, disease prevention, patient engagement,
and informed decision-making, ultimately supporting more equitable and effective health outcomes across CIBEM’s six clinical specialties.
Indigenous systems of medicine contain their own conceptual frameworks for explaining the biological, psychological, and social dimensions of health and disease. AIMS-ES seeks to study these frameworks on their own terms and
investigate how they may complement contemporary biopsychosocial understandings of health. Questions of therapeutic efficacy, however, require a different standard of inquiry. Interventions derived from these systems must
be evaluated using rigorous contemporary research designs, transparent measurement, appropriate statistical methods, and reproducible evidence. AIMS-ES brings these two approaches together, preserving indigenous explanatory
perspectives while subjecting claims of efficacy and clinical relevance to rigorous empirical evaluation across CIBEM’s six clinical disciplines: psychiatry, neurology, immunology, infectious diseases, endocrinology, and
dentistry.